| Serial Number | 87421067 |
| Word Mark | CYTOMX |
| Filing Date | Friday, April 21, 2017 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 29, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 26, 2017 |
| Goods and Services | Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; diagnostic kits for scientific, laboratory, and research use comprising proteolytically-activatable or protease-activatable, proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells, and antigens; immunoglobulin and antigen-binding fragments for drug conjugation and targeted cell binding for laboratory and research use; assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use |
| Goods and Services | infections, inflammation; infections, inflammation; infections, inflammation; engineered cell therapies for medical purposes, namely, for use in treating cancer, infections, autoimmunity, and inflammation; infections, inflammation; assays and reagents for use in medical, medical diagnostic and therapeutic purposes for proteolytic activation and binding to tumor cells; biochemical test kits comprised of assays and reagents for medical, medical diagnostic and therapeutic purposes for proteolytic activation and binding to tumor cells; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery for medical, medical diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for use in identifying candidate patient populations for specific therapeutic treatments for medical purposes; therapeutic kits comprising proteolytically-activatable or protease-activatable, proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells, and antigens |
| Goods and Services | Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy, oncology and dysregulated proteolytic activity; medical and scientific research and development for agents, preparations, products and technology in the field of dysregulated proteolytic activities; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, oncology and dysregulated proteolytic activity; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating to biochemicals, engineered cell therapies and immunotherapy, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services; online computer services in the nature of providing a search engine for obtaining data, namely, searching, retrieving, and providing information on antibodies and research topics pertaining to antibodies on a global computer network |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 28, 2017 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 28, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 28, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CytomX Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | CytomX Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Monday, March 29, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 29, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, August 12, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 11, 2020 | EXTENSION 5 GRANTED |
| Wednesday, July 29, 2020 | EXTENSION 5 FILED |
| Monday, August 10, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, August 3, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, July 29, 2020 | TEAS EXTENSION RECEIVED |
| Friday, February 7, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 5, 2020 | EXTENSION 4 GRANTED |
| Wednesday, February 5, 2020 | EXTENSION 4 FILED |
| Wednesday, February 5, 2020 | TEAS EXTENSION RECEIVED |
| Thursday, January 30, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, January 30, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, January 21, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, January 21, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 16, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 16, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, August 22, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 19, 2019 | EXTENSION 3 GRANTED |
| Monday, August 19, 2019 | EXTENSION 3 FILED |
| Monday, August 19, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, February 19, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 15, 2019 | EXTENSION 2 GRANTED |
| Friday, February 15, 2019 | EXTENSION 2 FILED |
| Friday, February 15, 2019 | TEAS EXTENSION RECEIVED |
| Friday, September 21, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 21, 2018 | CORRECTED NOA E-MAILED |
| Thursday, September 20, 2018 | EXTENSION 1 GRANTED |
| Monday, August 20, 2018 | EXTENSION 1 FILED |
| Thursday, September 20, 2018 | DIVISIONAL PROCESSING COMPLETE |
| Monday, August 20, 2018 | DIVISIONAL REQUEST RECEIVED |
| Monday, September 17, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, August 20, 2018 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, August 20, 2018 | TEAS EXTENSION RECEIVED |
| Monday, February 26, 2018 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Tuesday, February 20, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, February 16, 2018 | ASSIGNED TO PETITION STAFF |
| Tuesday, February 6, 2018 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, December 26, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 26, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 6, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 14, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, November 14, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, November 14, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 14, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 14, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, November 9, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 8, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 8, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 24, 2017 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, July 24, 2017 | PRIORITY ACTION E-MAILED |
| Monday, July 24, 2017 | PRIORITY ACTION WRITTEN |
| Monday, July 17, 2017 | ASSIGNED TO EXAMINER |
| Friday, April 28, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, April 25, 2017 | NEW APPLICATION ENTERED IN TRAM |